Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$485.99 USD
+4.10 (0.85%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $486.28 +0.29 (0.06%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/1/24 |
---|---|
Current Quarter | 4.09 |
EPS Last Quarter | 4.76 |
Last EPS Surprise | 16.10% |
ABR | 1.80 |
Earnings ESP
|
0.41% |
---|---|
Current Year | 16.94 |
Next Year | 17.71 |
EPS (TTM) | 16.93 |
P/E (F1) | 28.45 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.63B | 2.68B | 10.72B | 11.59B |
# of Estimates | 10 | 10 | 11 | 11 |
High Estimate | 2.70B | 2.72B | 10.83B | 13.12B |
Low Estimate | 2.55B | 2.65B | 10.65B | 11.17B |
Year ago Sales | 2.49B | 2.48B | 9.87B | 10.72B |
Year over Year Growth Est. | 5.30% | 7.87% | 8.64% | 8.09% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.09 | 4.00 | 16.94 | 17.71 |
# of Estimates | 11 | 9 | 11 | 12 |
Most Recent Consensus | 4.02 | 4.08 | 16.79 | 17.18 |
High Estimate | 4.37 | 4.30 | 17.74 | 22.47 |
Low Estimate | 3.59 | 3.78 | 16.12 | 15.44 |
Year ago EPS | 3.89 | 4.08 | 15.23 | 16.94 |
Year over Year Growth Est. | 5.14% | -1.96% | 11.23% | 4.53% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 4.09 | 4.00 | 16.94 | 17.71 |
7 Days Ago | 4.09 | 4.00 | 16.94 | 17.71 |
30 Days Ago | 4.09 | 4.00 | 16.94 | 17.71 |
60 Days Ago | 4.13 | 4.05 | 17.03 | 17.90 |
90 Days Ago | 4.04 | 4.12 | 16.91 | 18.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 4.11 | 4.00 | 16.61 | 17.42 |
Zacks Consensus Estimate | 4.09 | 4.00 | 16.94 | 17.71 |
Earnings ESP | 0.41% | -0.11% | -1.94% | -1.61% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 4.76 | 4.20 | 4.08 | 3.89 | NA |
Estimate | 4.10 | 4.10 | 3.92 | 3.85 | NA |
Difference | 0.66 | 0.10 | 0.16 | 0.04 | 0.24 |
Surprise | 16.10% | 2.44% | 4.08% | 1.04% | 5.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more